Select Medical Holdings (SEM) Equity Income (2018 - 2026)

Select Medical Holdings has disclosed Equity Income across 9 years of filings, most recently posting $12.0 million for Q1 2026.

• In Q1 2026, Equity Income fell 4.0% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $54.0 million (down 13.32% YoY), while the FY2025 annual figure was $54.5 million, down 9.48% from the prior year.
• Equity Income declined to $12.0 million in Q1 2026, from $15.4 million in the prior quarter.
• Over the last five years, Equity Income for SEM reached as high as $33.1 million in Q3 2024 and fell as low as $5.4 million in Q1 2022.
• The 5-year median for Equity Income is $10.4 million (2024), against an average of $11.4 million.
• Annual changes were most pronounced in 2024 — Equity Income soared 186.04% — and 2025, when it slumped 60.71%.
• A 5-year view of Equity Income shows it stood at $6.8 million in 2022, then surged by 50.84% to $10.2 million in 2023, then climbed by 2.24% to $10.4 million in 2024, then surged by 47.74% to $15.4 million in 2025, then decreased by 22.0% to $12.0 million in 2026.
• According to Business Quant data, Equity Income over the past three periods registered $12.0 million, $15.4 million, and $13.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.